Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an EGFR mutation

BACKGROUND: Non-small cell lung cancer (NSCLC) harboring EGFR-sensitizing mutations has a distinct biology and heterogeneous clinical behavior. We evaluated the characteristics to progression such as clinical patterns of progression (dramatic, gradual, and local) with the prognosis of NSCLC patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Barrón, Feliciano, Cardona, Andrés F., Corrales, Luis, Ramirez-Tirado, Laura-Alejandra, Caballe-Perez, Enrique, Sanchez, Gisela, Flores-Estrada, Diana, Zatarain-Barrón, Zyanya Lucia, Arrieta, Oscar
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5949490/
https://ncbi.nlm.nih.gov/pubmed/29850120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.03.106
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados